Rexulti
- Product NDC
- 59148-039
- 11-digit product format
- 591480039
- Labeler code
- 59148
- Product ID
- 59148-039_3a208135-0d99-4d6a-b73e-61d63cf48f4f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- brexpiprazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Otsuka America Pharmaceutical, Inc.
- Application
- NDA205422
- Marketing category
- NDA
- Marketing start
- 2015-07-10
- Substance
- BREXPIPRAZOLE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rexulti
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BREXPIPRAZOLE | 3 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2J3YBM1K8C |
| Rxcui | 1658319, 1658325, 1658327, 1658329, 1658331, 1658333, 1658335, 1658337, 1658339, 1658341, 1658343, 1658345 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| brexpiprazole | ACTIVE INGREDIENT | 2J3YBM1K8C | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| brexpiprazole | ACTIVE MOIETY | 2J3YBM1K8C | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| hydroxypropyl cellulose (type h) | INACTIVE INGREDIENT | RFW2ET671P | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| hydroxypropyl cellulose, low substituted | INACTIVE INGREDIENT | 2165RE0K14 | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| lactose monohydrate | INACTIVE INGREDIENT | EWQ57Q8I5X | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| starch, corn | INACTIVE INGREDIENT | O8232NY3SJ | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | REXULTI (BREXPIPRAZOLE) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59148-039 | REXULTI (BREXPIPRAZOLE) TABLET REXULTI (BREXPIPRAZOLE) KIT [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 24 | Current NDC, Legacy NDC, 4 package rows | 20250519_2d301358-6291-4ec1-bd87-37b4ad9bd850.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59148-039-07 | 59148003907 | 1 BLISTER PACK in 1 CARTON (59148-039-07) / 7 TABLET in 1 BLISTER PACK | 1 blister pack | 2015-07-10 | | Yes | No | Current |
| 59148-039-13 | 59148003913 | 1 BOTTLE in 1 CARTON (59148-039-13) / 30 TABLET in 1 BOTTLE | 1 bottle | 2015-07-10 | 0000-00-00 | No | No | Current |